These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1889628)
1. Chirality and its importance in drug development: an analytical chemist's perspective. Fell AF; Ley GW Biochem Soc Trans; 1991 Apr; 19(2):454-6. PubMed ID: 1889628 [No Abstract] [Full Text] [Related]
2. Chirality and its importance in drug development: a synthetic chemist's perspective. Roberts SM Biochem Soc Trans; 1991 Apr; 19(2):446-53. PubMed ID: 1889627 [No Abstract] [Full Text] [Related]
3. The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. Roughley SD; Jordan AM J Med Chem; 2011 May; 54(10):3451-79. PubMed ID: 21504168 [No Abstract] [Full Text] [Related]
4. Chirality and its importance in drug development. Campbell DB; Wilson K Biochem Soc Trans; 1991 Apr; 19(2):472-5. PubMed ID: 1889635 [No Abstract] [Full Text] [Related]
6. Chirality and its importance in drug development: what are the issues? Beckett AH Biochem Soc Trans; 1991 Apr; 19(2):443-6. PubMed ID: 1889626 [No Abstract] [Full Text] [Related]
7. A medicinal chemistry perspective on structure-based drug design and development. Maddaford SP Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460 [TBL] [Abstract][Full Text] [Related]
8. High-throughput and parallel screening methods in asymmetric hydrogenation. Jäkel C; Paciello R Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304 [No Abstract] [Full Text] [Related]
9. Biocatalysis: synthesis of chiral intermediates for drugs. Patel RN Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684 [TBL] [Abstract][Full Text] [Related]
10. Sustainable Practices in Medicinal Chemistry Part 2: Green by Design. Aliagas I; Berger R; Goldberg K; Nishimura RT; Reilly J; Richardson P; Richter D; Sherer EC; Sparling BA; Bryan MC J Med Chem; 2017 Jul; 60(14):5955-5968. PubMed ID: 28375009 [TBL] [Abstract][Full Text] [Related]
11. Parallel chemistry in the 21st century. Long A Curr Protoc Pharmacol; 2012 Sep; Chapter 9():Unit9.16. PubMed ID: 22948852 [TBL] [Abstract][Full Text] [Related]
12. Open-access high-resolution mass spectrometry in early drug discovery. Thomas SR; Gerhard U J Mass Spectrom; 2004 Aug; 39(8):942-8. PubMed ID: 15329846 [TBL] [Abstract][Full Text] [Related]
15. Analytical chemistry for drug discovery and development. Roda A Anal Bioanal Chem; 2010 Sep; 398(1):27-8. PubMed ID: 20652554 [No Abstract] [Full Text] [Related]
16. Asymmetric syntheses and transformations--tools for chirality multiplication in drug synthesis. Gawroński J Acta Pol Pharm; 2006; 63(5):333-51. PubMed ID: 17357583 [TBL] [Abstract][Full Text] [Related]
17. Designing active template molecules by combining computational de novo design and human chemist's expertise. Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122 [TBL] [Abstract][Full Text] [Related]
18. Combinatorial chemistry hits the drug market. Service RF Science; 1996 May; 272(5266):1266-8. PubMed ID: 8650537 [No Abstract] [Full Text] [Related]
19. March of the synthesis machines. Sanderson K Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572 [No Abstract] [Full Text] [Related]